1. Home
  2. TRIN vs WVE Comparison

TRIN vs WVE Comparison

Compare TRIN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIN
  • WVE
  • Stock Information
  • Founded
  • TRIN 2007
  • WVE 2012
  • Country
  • TRIN United States
  • WVE Singapore
  • Employees
  • TRIN N/A
  • WVE N/A
  • Industry
  • TRIN Finance/Investors Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRIN Finance
  • WVE Health Care
  • Exchange
  • TRIN Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TRIN 912.3M
  • WVE 984.9M
  • IPO Year
  • TRIN 2021
  • WVE 2015
  • Fundamental
  • Price
  • TRIN $14.56
  • WVE $6.01
  • Analyst Decision
  • TRIN Hold
  • WVE Strong Buy
  • Analyst Count
  • TRIN 3
  • WVE 11
  • Target Price
  • TRIN $14.83
  • WVE $20.91
  • AVG Volume (30 Days)
  • TRIN 495.3K
  • WVE 1.5M
  • Earning Date
  • TRIN 05-07-2025
  • WVE 05-08-2025
  • Dividend Yield
  • TRIN 14.01%
  • WVE N/A
  • EPS Growth
  • TRIN 37.77
  • WVE N/A
  • EPS
  • TRIN 2.19
  • WVE N/A
  • Revenue
  • TRIN $240,010,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • TRIN $24.43
  • WVE N/A
  • Revenue Next Year
  • TRIN $6.17
  • WVE N/A
  • P/E Ratio
  • TRIN $6.65
  • WVE N/A
  • Revenue Growth
  • TRIN 30.65
  • WVE N/A
  • 52 Week Low
  • TRIN $12.50
  • WVE $4.25
  • 52 Week High
  • TRIN $16.82
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TRIN 49.02
  • WVE 39.86
  • Support Level
  • TRIN $14.28
  • WVE $5.89
  • Resistance Level
  • TRIN $14.78
  • WVE $6.30
  • Average True Range (ATR)
  • TRIN 0.22
  • WVE 0.32
  • MACD
  • TRIN 0.01
  • WVE 0.01
  • Stochastic Oscillator
  • TRIN 36.35
  • WVE 10.17

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: